Bank of America’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $770K | Buy |
224,365
+208,390
| +1,304% | +$715K | ﹤0.01% | 4591 |
|
|
2025
Q1 | $35.6K | Sell |
15,975
-1,166
| -7% | -$2.6K | ﹤0.01% | 5816 |
|
|
2024
Q4 | $50.2K | Sell |
17,141
-1,936
| -10% | -$5.67K | ﹤0.01% | 5744 |
|
|
2024
Q3 | $49.6K | Buy |
19,077
+8,837
| +86% | +$23K | ﹤0.01% | 5658 |
|
|
2024
Q2 | $30.3K | Sell |
10,240
-146,843
| -93% | -$435K | ﹤0.01% | 5782 |
|
|
2024
Q1 | $712K | Sell |
157,083
-14,433
| -8% | -$65.4K | ﹤0.01% | 4352 |
|
|
2023
Q4 | $979K | Sell |
171,516
-5,018
| -3% | -$28.7K | ﹤0.01% | 4157 |
|
|
2023
Q3 | $812K | Buy |
176,534
+133,771
| +313% | +$615K | ﹤0.01% | 4167 |
|
|
2023
Q2 | $276K | Sell |
42,763
-122,598
| -74% | -$792K | ﹤0.01% | 4808 |
|
|
2023
Q1 | $1.25M | Buy |
165,361
+67,932
| +70% | +$512K | ﹤0.01% | 4069 |
|
|
2022
Q4 | $987K | Buy |
97,429
+21,067
| +28% | +$213K | ﹤0.01% | 4223 |
|
|
2022
Q3 | $756K | Buy |
76,362
+31,984
| +72% | +$317K | ﹤0.01% | 4377 |
|
|
2022
Q2 | $473K | Buy |
44,378
+32,734
| +281% | +$349K | ﹤0.01% | 4774 |
|
|
2022
Q1 | $113K | Buy |
11,644
+7,536
| +183% | +$73.1K | ﹤0.01% | 6010 |
|
|
2021
Q4 | $59K | Buy |
4,108
+1,661
| +68% | +$23.9K | ﹤0.01% | 6293 |
|
|
2021
Q3 | $49K | Sell |
2,447
-84,269
| -97% | -$1.69M | ﹤0.01% | 6161 |
|
|
2021
Q2 | $1.91M | Buy |
86,716
+86,715
| +8,671,500% | +$1.91M | ﹤0.01% | 3777 |
|
|
2021
Q1 | $0 | Buy |
+1
| New | – | ﹤0.01% | 6661 |
|